Credit Suisse’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $8.2M | Sell |
201,642
-2,131
| -1% | -$79.9K | 0.01% | 1021 |
|
|
2023
Q4 | $7.53M | Sell |
203,773
-3,574
| -2% | -$135K | 0.01% | 1094 |
|
|
2023
Q3 | $7.92M | Sell |
207,347
-19,272
| -9% | -$789K | 0.01% | 1013 |
|
|
2023
Q2 | $8.17M | Buy |
226,619
+48,436
| +27% | +$1.65M | 0.01% | 1026 |
|
|
2023
Q1 | $6.8M | Buy |
178,183
+4,038
| +2% | +$189K | 0.01% | 1122 |
|
|
2022
Q4 | $9.91M | Buy |
174,145
+3,684
| +2% | +$189K | 0.01% | 940 |
|
|
2022
Q3 | $6.74M | Buy |
170,461
+4,682
| +3% | +$207K | 0.01% | 1102 |
|
|
2022
Q2 | $7.29M | Sell |
165,779
-3,073
| -2% | -$133K | 0.01% | 1080 |
|
|
2022
Q1 | $6.73M | Buy |
168,852
+813
| +0.5% | +$29K | 0.01% | 1260 |
|
|
2021
Q4 | $6.76M | Sell |
168,039
-7,099
| -4% | -$265K | ﹤0.01% | 1787 |
|
|
2021
Q3 | $7.13M | Buy |
175,138
+24,482
| +16% | +$1.02M | ﹤0.01% | 1778 |
|
|
2021
Q2 | $6.84M | Sell |
150,656
-4,876
| -3% | -$216K | ﹤0.01% | 1829 |
|
|
2021
Q1 | $6.48M | Sell |
155,532
-104,386
| -40% | -$4.77M | ﹤0.01% | 1861 |
|
|
2020
Q4 | $11.1M | Buy |
259,918
+96,066
| +59% | +$3.45M | 0.01% | 1511 |
|
|
2020
Q3 | $4.31M | Sell |
163,852
-63,178
| -28% | -$1.76M | ﹤0.01% | 1885 |
|
|
2020
Q2 | $6.09M | Buy |
227,030
+129,379
| +132% | +$2.92M | ﹤0.01% | 1586 |
|
|
2020
Q1 | $1.76M | Sell |
97,651
-80,336
| -45% | -$1.52M | ﹤0.01% | 2220 |
|
|
2019
Q4 | $3.15M | Buy |
177,987
+29,824
| +20% | +$517K | ﹤0.01% | 2244 |
|
|
2019
Q3 | $2.3M | Sell |
148,163
-78,335
| -35% | -$1.29M | ﹤0.01% | 2370 |
|
|
2019
Q2 | $3.89M | Buy |
226,498
+23,625
| +12% | +$381K | ﹤0.01% | 1945 |
|
|
2019
Q1 | $3.27M | Buy |
202,873
+46,208
| +29% | +$749K | ﹤0.01% | 2026 |
|
|
2018
Q4 | $2.29M | Buy |
156,665
+60,375
| +63% | +$963K | ﹤0.01% | 2134 |
|
|
2018
Q3 | $1.75M | Sell |
96,290
-14,539
| -13% | -$255K | ﹤0.01% | 2450 |
|
|
2018
Q2 | $1.87M | Sell |
110,829
-40,296
| -27% | -$762K | ﹤0.01% | 2526 |
|
|
2018
Q1 | $2.96M | Buy |
151,125
+27,353
| +22% | +$530K | ﹤0.01% | 2107 |
|
|
2017
Q4 | $2.51M | Sell |
123,772
-151,686
| -55% | -$2.79M | ﹤0.01% | 2261 |
|
|
2017
Q3 | $4.78M | Buy |
275,458
+28,945
| +12% | +$392K | ﹤0.01% | 1798 |
|
|
2017
Q2 | $3.16M | Sell |
246,513
-14,861
| -6% | -$198K | ﹤0.01% | 1911 |
|
|
2017
Q1 | $3.39M | Buy |
261,374
+128,861
| +97% | +$1.63M | ﹤0.01% | 1936 |
|
|
2016
Q4 | $1.31M | Sell |
132,513
-380,408
| -74% | -$4.17M | ﹤0.01% | 2809 |
|
|
2016
Q3 | $6.2M | Buy |
512,921
+7,269
| +1% | +$74.3K | 0.01% | 1497 |
|
|
2016
Q2 | $4.36M | Sell |
505,652
-23,395
| -4% | -$231K | ﹤0.01% | 1730 |
|
|
2016
Q1 | $5.01M | Buy |
529,047
+38,061
| +8% | +$358K | 0.01% | 1528 |
|
|
2015
Q4 | $8.51M | Sell |
490,986
-69,948
| -12% | -$1.11M | 0.01% | 1254 |
|
|
2015
Q3 | $7.53M | Sell |
560,934
-87,914
| -14% | -$1.77M | 0.01% | 1288 |
|
|
2015
Q2 | $14.7M | Buy |
648,848
+78,418
| +14% | +$1.38M | 0.01% | 1010 |
|
|
2015
Q1 | $8.15M | Sell |
570,430
-22,443
| -4% | -$324K | 0.01% | 1323 |
|
|
2014
Q4 | $5.72M | Buy |
592,873
+71,572
| +14% | +$636K | 0.01% | 1659 |
|
|
2014
Q3 | $4.74M | Buy |
521,301
+188,689
| +57% | +$1.8M | ﹤0.01% | 1790 |
|
|
2014
Q2 | $3.29M | Sell |
332,612
-186,381
| -36% | -$1.58M | ﹤0.01% | 2315 |
|
|
2014
Q1 | $6.59M | Buy |
518,993
+173,177
| +50% | +$2.57M | 0.01% | 1540 |
|
|
2013
Q4 | $5.18M | Buy |
345,816
+2,670
| +0.8% | +$34.3K | ﹤0.01% | 1818 |
|
|
2013
Q3 | $3.79M | Buy |
343,146
+173,514
| +102% | +$1.45M | ﹤0.01% | 1868 |
|
|
2013
Q2 | $1.35M | Buy |
+169,632
| New | +$1.08M | ﹤0.01% | 2565 |
|
Other funds holding HALO
SCM
Credit Suisse's HALO Position: Q1 2024 in Review
Credit Suisse reduced its Halozyme (HALO) stake by 1% in Q1 2024, selling an estimated $79.9K and leaving 201,642 shares worth $8.2M. The position accounts for 0.01% of the portfolio, ranked #1021.
Credit Suisse first reported a position in HALO in Q2 2013 and has held it in 44 quarters since. The position peaked at $14.7M in Q2 2015. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.
- Credit Suisse held 201,642 shares of Halozyme worth $8.2M as of Q1 2024.
- Credit Suisse sold 2,131 Halozyme shares in Q1 2024, an estimated $79.9K.
- Halozyme made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1021 holding.
- Credit Suisse first reported a position in Halozyme in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Halozyme position peaked at $14.7M in Q2 2015.
- 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.